arctigenin has been researched along with Pulmonary Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Li, X; Pu, S; Wang, X; Wang, Y; Wang, Z; Zhang, L | 1 |
| Deng, Y; Jiang, L; Li, W; Lu, Y | 1 |
2 other study(ies) available for arctigenin and Pulmonary Fibrosis
| Article | Year |
|---|---|
Ameliorative Effects of Arctigenin on Pulmonary Fibrosis Induced by Bleomycin via the Antioxidant Activity.
Topics: Animals; Antioxidants; Bleomycin; Collagen; Fibrosis; Furans; Glutathione; Lignans; Lung; Mice; Pulmonary Fibrosis | 2022 |
Arctigenin suppresses fibroblast activity and extracellular matrix deposition in hypertrophic scarring by reducing inflammation and oxidative stress.
Topics: Animals; Antioxidants; Bleomycin; Cicatrix, Hypertrophic; Cytokines; Disease Models, Animal; Extracellular Matrix; Female; Fibroblasts; Fibrosis; Furans; Inflammation; Lignans; Malondialdehyde; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Oxidative Stress; Pulmonary Fibrosis; Superoxide Dismutase; Transforming Growth Factor beta1 | 2020 |